REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 152 filers reported holding REATA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 3.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $10,094 | +19.4% | 99 | +6.5% | 0.00% | – |
| Q1 2023 | $8,456 | +161.9% | 93 | +9.4% | 0.00% | – |
| Q4 2022 | $3,229 | +61.4% | 85 | +41.7% | 0.00% | – |
| Q3 2022 | $2,000 | -50.0% | 60 | -49.2% | 0.00% | – |
| Q2 2022 | $4,000 | -55.6% | 118 | -57.1% | 0.00% | – |
| Q1 2022 | $9,000 | +125.0% | 275 | +685.7% | 0.00% | – |
| Q3 2021 | $4,000 | -33.3% | 35 | -18.6% | 0.00% | – |
| Q2 2021 | $6,000 | +200.0% | 43 | +72.0% | 0.00% | – |
| Q1 2021 | $2,000 | +100.0% | 25 | +177.8% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 9 | -35.7% | 0.00% | – |
| Q3 2020 | $1,000 | – | 14 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |